Sukhtian Faisal Ghiath — SEC Form 4 filings

SEC reporting owner CIK 1716033. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-08 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Outlook Therapeutics, Inc. (OTLK)Director62 legs · 217,572 sh · $150,0027

Form 4 filings — Sukhtian Faisal Ghiath

FiledFormIssuerReported transactionsSource
2026-07-294Outlook Therapeutics, Inc. (OTLK)Purchase (P): 95,398 @ $1.05EDGAR
2026-05-274Outlook Therapeutics, Inc. (OTLK)Purchase (P): 122,174 @ $0.41EDGAR
2025-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 117,296 (derivative) @ $0EDGAR
2025-02-064Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 12,323 (derivative) @ $0EDGAR
2024-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 56,636 (derivative) @ $0 · Grant/award (A): 134,430 (derivative) @ $0 · Grant/award (A): 19,771 (derivative) @ $0EDGAR
2024-03-084Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 94,441 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1716033 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →